当前位置：首页 > 文献互助 > 互助详情

Tozorakimab to Prevent COPD Exacerbations复制

用户zCL_XFDWAdZs 28分钟前 9 10 待确认 帖子自动结束时间: 2026-09-14 10:08:00

1. 请及时下载文件确认是否正确, 系统将在 2026-09-16 10:32:29 删除文件

2. 如若文件有误请驳回应助文件, 求助状态即回到求助中

3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1056/NEJMoa2606998复制

文献链接: http://www.nejm.org/doi/10.1056/NEJMoa2606998复制

其他信息:

出版社: Massachusetts Medical Society
作者: Frank C. Sciurba; Henrik Watz; Arnaud Bourdin; Wim Janssens; Fernando J. Martinez; Jinping Zheng; Maarten van den Berge; Matteo Bonini; MeiLan K. Han; Dave Singh; Gerard J. Criner; Christopher E. Brightling; Alberto Papi; Surya P. Bhatt; Martin Jenkins; Marta Mikosz; Piotr Chołbiński; Monika Ziemiecka; Magnus Löfdahl; Deepa Arya; Madhavi Yadavalli; Bryan H. Brodek; Malin Fagerås; Samuel Bardsley; Neil Martin; Rajesh Patel; Ioannis Psallidas

上一篇：Hydroxychloroquine for prevention of recurrent miscarriage in France (BBQ): a prospective, multicentre, randomised, placebo-controlled, double-blind, phase 3 trial

下一篇：Characterization of a new crystalline synthetic gastric antacid, almagate

互助时间线

2026-09-09 10:32:29 [上传文件]

甜蜜蜜2023上传了文件(pdf 281.00 B), 求助状态变成 待确认

2026-09-09 10:08:00 [发起求助]

最新发布的求助

Once‑weekly IcoSema versus once‑weekly insulin icodec in type 2 diabetes management (COMBINE 1): an open‑label, multicentre, treat‑to‑target, randomised, phase 3a trial 15分钟前
Characterization of a new crystalline synthetic gastric antacid, almagate 17分钟前
Characterization of a new crystalline synthetic gastric antacid, almagate 26分钟前
Tozorakimab to Prevent COPD Exacerbations 28分钟前
Hydroxychloroquine for prevention of recurrent miscarriage in France (BBQ): a prospective, multicentre, randomised, placebo-controlled, double-blind, phase 3 trial 33分钟前
International Breast Cancer Trials and Optimal Sequence of Treatment 38分钟前
The Long Revolution (Part I) 50分钟前
Fibrotic-like collagen matrices as 3D in vitro models for investigating the impact of pathological extracellular matrix on skeletal muscle cell behavior 2小时前
First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations 8小时前
Efficacy and safety of sunvozertinib monotherapy as first-line treatment in NSCLC patients with EGFR exon 20 insertion mutations: A phase 2, single-center trial 9小时前
Influence of Solvents and Additives on the Pyrophoricity of Palladium on Carbon Catalyst after Hydrogenation 11小时前
The English Working Class 11小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com